---
figid: PMC11733248__41392_2024_2097_Fig2_HTML
figtitle: Current therapeutic targets in gastric cancer and GEJ adenocarcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11733248
filename: 41392_2024_2097_Fig2_HTML.jpg
figlink: /pmc/articles/PMC11733248/figure/F2/
number: F2
caption: Current therapeutic targets in gastric cancer and GEJ adenocarcinoma. 5-FU
  5-fluorouracil, VEGFR vascular endothelial growth factor receptor, HER2 human epidermal
  growth factor receptor 2, CLDN18.2 claudin 18.2, PD-1 programmed cell death protein
  1, FGFR2b fibroblast growth factor receptor 2b, DKK1 Dickkopf WNT signaling pathway
  inhibitor 1. Therapies that are recommended by international guidelines are marked
  in red. Therapies with preclinical or only low levels of clinical evidence are highlighted
  in blue
papertitle: 'Digestive cancers: mechanisms, therapeutics and management'
reftext: Tianzuo Zhan, et al. Signal Transduct Target Ther. 2025;10(NA).
year: '2025'
doi: 10.1038/s41392-024-02097-4
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group
keywords: Gastrointestinal cancer | Gastrointestinal cancer
automl_pathway: 0.9642158
figid_alias: PMC11733248__F2
figtype: Figure
redirect_from: /figures/PMC11733248__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11733248__41392_2024_2097_Fig2_HTML.html
  '@type': Dataset
  description: Current therapeutic targets in gastric cancer and GEJ adenocarcinoma.
    5-FU 5-fluorouracil, VEGFR vascular endothelial growth factor receptor, HER2 human
    epidermal growth factor receptor 2, CLDN18.2 claudin 18.2, PD-1 programmed cell
    death protein 1, FGFR2b fibroblast growth factor receptor 2b, DKK1 Dickkopf WNT
    signaling pathway inhibitor 1. Therapies that are recommended by international
    guidelines are marked in red. Therapies with preclinical or only low levels of
    clinical evidence are highlighted in blue
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KDR
  - FLT1
  - FLT4
  - CARTPT
  - DKK1
  - ERBB2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - KRAS
  - HRAS
  - NRAS
  - PDK1
  - PDPK1
  - MAP2K2
  - MAP2K1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - MTOR
  - dkk1b
  - her2
  - fgfr2
  - rab1ab
  - pdk1
  - map2k2a
  - map2k1
  - mapk3
  - mtor
  - Oxaliplatin
  - Cisplatin
  - RAS
  - TAS-102
  - Paclitaxel
  - Irinotecan
---
